Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141923 |
| CAS No | NA |
| Mol.F. | C19H23N3O5 |
| Mol.Wt. | 373.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141924 |
| CAS No | NA |
| Mol.F. | C18H21N3O5 |
| Mol.Wt. | 359.38 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141925 |
| CAS No | NA |
| Mol.F. | C20H25N3O5 |
| Mol.Wt. | 387.44 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141926 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141927 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141928 |
| CAS No | NA |
| Mol.F. | C19H23N3O5 |
| Mol.Wt. | 373.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141929 |
| CAS No | NA |
| Mol.F. | C18H23N3O4 |
| Mol.Wt. | 345.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141930 |
| CAS No | NA |
| Mol.F. | C18H21N3O5 |
| Mol.Wt. | 359.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141931 |
| CAS No | NA |
| Mol.F. | C20H25N3O5 |
| Mol.Wt. | 387.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141932 |
| CAS No | NA |
| Mol.F. | C32H35N7O7 |
| Mol.Wt. | 629.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141933 |
| CAS No | NA |
| Mol.F. | C34H39N7O7 |
| Mol.Wt. | 657.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141934 |
| CAS No | NA |
| Mol.F. | C32H36N8O6 |
| Mol.Wt. | 628.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141935 |
| CAS No | NA |
| Mol.F. | C33H38N8O6 |
| Mol.Wt. | 642.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141936 |
| CAS No | NA |
| Mol.F. | C8H6N3O5 |
| Mol.Wt. | 224.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141937 |
| CAS No | NA |
| Mol.F. | C9H7N3O3 |
| Mol.Wt. | 205.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141938 |
| CAS No | NA |
| Mol.F. | C27H25N7O4 |
| Mol.Wt. | 511.5 g/mol |
| INV STATUS | In Stock |